Registry of Outcomes of Dezawa MuseCells®
Recruiting · NCT07645989 · Observational (researchers observe without assigning treatment) · Lead sponsor: MuseCell Innovations Pte LTD
View the official record on ClinicalTrials.gov →Interventions studied
MuseCell Treatment
What this trial is about
The goal of this observational study is to learn about the long-term effects of Dezawa MuseCells to treat various diseases. The Primary Goal: What is the short-term and long- term outcomes of Dezawa Musecells? Participants treated with Dezawa MuseCells as part of their regular medical care and will answer online survey questions about symptoms and clinical outcomes for 5 years.
Who can take part
Age range
Up to 89 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Received Dezawa MuseCells® as Part of Routine Clinical Care
- Patients ( and/or authorized representative) capable of providing informed consent and participating in long-term follow-up.
- Willingness to Complete Online Survey Assessments
- Participants must have reliable access to email or a mobile device and be willing to complete digital surveys at scheduled intervals over a 5-year period.
- Diagnosis of a Condition for Which Dezawa MuseCells® Were Administered Includes, but is not limited to, neurologic, musculoskeletal, cardiovascular, immunologic, and systemic degenerative conditions.
- Ability to Communicate in the Registry's Supported Language
- Participants must be able to read and respond to registry surveys in the designated study language.
- Enrollment Within 12 Months of MuseCell® Administration
Exclusion criteria
- Not Receive Dezawa MuseCells®-Individuals who have not been treated with Dezawa MuseCells® or received a counterfeit/non-licensed product cannot be included.
- Unable or Unwilling to Provide Informed Consent Includes individuals with cognitive impairment who lack a legally authorized representative willing to consent on their behalf.
- Inability to Participate in Long-Term Digital Follow-Up
- Concurrent Participation in an Interventional Clinical Trial Affecting Outcomes
- History of Malignancy Diagnosed Within the Past 12 Months
- Excludes patients with active or recently treated cancer unless their treating physician determines participation poses no additional safety concerns.
- Any Condition That, in the Investigator's Judgment, Would Compromise Data Quality
- Use of Non-Licensed or Counterfeit "Muse-like" Cells Ensures that registry data reflect outcomes of authentic Dezawa MuseCells® produced under licensed methods.
- Pregnant or Actively Breastfeeding at Time of Enrollment
Where it is running
2 locations listed across 1 US state.
- Bioreset Medical - North Palm Beach, Florida, United States
- Regene Labs - Guadalajara, Mexico